Investing.com - Financial Markets Worldwide

Torii Pharmaceutical Co Ltd (4551)

Tokyo
Currency in JPY
6,320.0
0.0(0.00%)
Closed·

4551 Financial Summary

Key Ratios

P/E Ratio21.96
Price/Book1.01
Debt / Equity0.35%
Return on Equity4.62%
Dividend Yield1.90%
EBITDA7.21B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa41,70046,98748,89654,63860,426
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa21,73824,33823,38022,75824,417
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa4,7394,6565,5415,0366,799
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa3,4953,3743,9444,1195,042
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa126,026130,810133,689133,432140,664
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa9,46112,37213,22112,50418,153
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa115,090117,014119,224120,133121,533
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-5,689.136523,439.13-8,716.53,003.38
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-3,443-1562,420-3,1233,639
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa7,625-1,498-13,676-3,779-3,571
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,425-1,546-1,698-3,835-3,944
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa2,756-3,201-12,954-10,738-3,876
* In Millions of JPY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 197.61%
Dividend Yield
1.90%
Industry Median 2.34%
Annualised payout
120.00
Paid unevenly
5-Years Growth
-
Growth Streak
Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 4,200.0
(-33.54% Downside)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
49.51 / --
Revenue / Forecast
14.68B / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Torii Pharmaceutical's earnings for the latest quarter?

The Torii Pharmaceutical EPS (TTM) is 197.61. Torii Pharmaceutical reported sales of 14,683.00, net income of 1,391.00, and EPS of 49.51 for the latest quarter.

What was Torii Pharmaceutical's net income for the latest quarter?

Torii Pharmaceutical's net income for the latest quarter was 1,391.00.

How did Torii Pharmaceutical's performance compare year-over-year in the latest quarter?

The company's revenue moved from 17,093.00 in the previous quarter to 14,683.00 in the latest quarter, and net income moved from 1,517.00 to 1,391.00 compared to the previous quarter.

What is Torii Pharmaceutical's net profit margin on a TTM basis?

Torii Pharmaceutical's trailing twelve months (TTM) net profit margin is 8.34%.

How does Torii Pharmaceutical's debt to equity ratio compare to industry standards?

Torii Pharmaceutical's total debt-to-equity ratio is 0.35%.

What is Torii Pharmaceutical's return on investment on a TTM basis?

Torii Pharmaceutical's trailing twelve months (TTM) return on investment (ROI) is 4.62%.

What were Torii Pharmaceutical's total assets and liabilities in the latest quarter?

As of the latest quarter, Torii Pharmaceutical reported total assets of 136,689.00 million and total liabilities of 14,551.00 million.

How has Torii Pharmaceutical's total revenue grown this year?

Torii Pharmaceutical's total revenue was 17,093.00 in the previous quarter and 14,683.00 in the latest quarter.

What is Torii Pharmaceutical's gross margin on a TTM basis?

Torii Pharmaceutical's trailing twelve months (TTM) gross margin is 40.67%.

What was Torii Pharmaceutical's revenue per share for the latest quarter?

Torii Pharmaceutical's revenue per share for the latest quarter was 1,864.60.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.